Oral Administration of Peptides; Absorption From Gastrointestinal Tract [clinicaltrials:NCT00468884]
Oral Administration of Peptides; Absorption From Gastrointestinal Tract [clinicaltrials:NCT00468884]
Bio2RDF identifier
NCT00468884
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00468884
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Context: Oral formulati ...... and 4.0
mg) or placebo.
brief title [clinicaltrials_vocabulary:brief-title]
Oral Administration of Peptides; Absorption From Gastrointestinal Tract
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2007-02-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The study was conducted ...... 120, 150, 180, 240, 300 min.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2007-05-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Kinetics of GLP-1 and PYY3-36; increasing oral doses
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-10-16T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00468884
official title [clinicaltrials_vocabulary:official-title]
Pharmacokinetics and Pharmacod ...... cept Study in Healthy Subjects
org study id [clinicaltrials_vocabulary:org-study-id]
Oral GLP-1 and PYY
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2006-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-10-01T00:00:00Z
identifier
clinicaltrials:NCT00468884
title
Oral Administration of Peptides; Absorption From Gastrointestinal Tract
@en
type
label
Oral Administration of Peptide ...... t [clinicaltrials:NCT00468884]
@en